Soligenix, Inc. (SNGX) – Corporate News
-
Soligenix, Inc. (SNGX) Prices $4.75 Million Public Offering
-
Soligenix, Inc. (SNGX) Announces FDA Grants Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SNGX Stock Lookup